Gene profiling of colonic serrated adenomas by using oligonucleotide microarray

International Journal of Colorectal Disease

Volumn 23, Issue 6, 2008, Pages 569-580

  Kim, Kyongrae ^a   Park, Ungchae ^a   Wang, Joonho ^a   Lee, Jaedong ^a   Park, Seunghwa ^a   Kim, Sangyoon ^a   Choi, Dongkug ^b   Kim, Changil ^b   Park, Jiyoung ^c  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Colorectal cancer; Gene expression; Oligonucleotide microarray; Serrated adenoma; Serrated pathway

Indexed keywords

ALPHA6 INTEGRIN; CELL CYCLE PROTEIN; COLECALCIFEROL RECEPTOR; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIN G1; EPHRIN RECEPTOR; GENE PRODUCT; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HISTONE DEACETYLASE 1; HOMEODOMAIN PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; MEMBRANE PROTEIN; NUCLEOPHOSMIN; PHOSPHOLIPASE A2; PROHIBITIN; PROTEIN BCL 2; PROTEIN BENE; PROTEIN BID; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RAS PROTEIN; RETINOIC ACID RECEPTOR ALPHA; RGS PROTEIN; SERINE PROTEINASE INHIBITOR; SIALYLTRANSFERASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE;

ARTICLE; CARCINOGENESIS; COLON ADENOMA; COLON MUCOSA; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECTUM MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UPREGULATION;

ADENOMA; AGED; CARRIER PROTEINS; COLONIC NEOPLASMS; COLONIC POLYPS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, RETINOIC ACID; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 41949135833     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0451-y     Document Type: Article

References (50)

1. Achord JL (1991) Hyperplastic colon polyps do not predict adenomas. Gastroenterology 100:1142-1143
2. Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR (2000) Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 119:323-332
3. Ansher AF, Lewis JH, Fleischer DE, Cattau EL Jr, Collen MJ, O'Kieffe DA, Korman LY, Benjamin SB (1989) Hyperplastic colonic polyps as a marker for adenomatous colonic polyps. Am J Gastroenterol 84:113-117
4. Itzkowitz SH, Bloom EJ, Lau TS, Kim YS (1992) Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps. Gut 33:518-523
5. Jass JR (1983) Relation between metaplastic polyp and carcinoma of the colorectum. Lancet 1:28-30
6. Kambara T, Simms LA, Whitehall VLJ, Spring KJ, Wynter CVA, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA (2004) BRAF mutation and CpG islamd methylation: an alternative pathway to colorectal cancer. Gut 53:1137-1144
7. Jass JR, Whitehall VLJ, Young J, Leggett B (2002) Emerging concepts in colorectal neoplasia. Gastroenterology 123:862-876
8. Jass JR (2001) Serrated route to colorectal cancer: Back street or super highway? J Pathol 193:283-285
9. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smitts AMM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532
10. Dong SM, Lee EJ, Jeon ES, Park CK, Kim KM (2004) Progressive methylation during the serrated neoplasia pathway of the colorectum. Mod Pathol 18(2):170-178
11. Jass JR, Biden KG, Cummings MC, Simms LA, Walsh M, Schoch E, Meltzer SJ, Wright C, Searle J, Young J, Leggett BA (1999) Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 52:455-460
12. Corman ML (2005) Colon and Rectal Surgery, 5th edn. Lippincott Williams & Wilkins, Philadelphia
13. Church JM (2004) Clinical significance of small colorectal polyps. Dis Colon Rectum 47:481-485
14. Yamauchi T, Watanabe M, Hasegawa H, Yamamoto S, Endo T, Kabeshima Y, Yorozuka K, Yamamoto K, Kitajima M (2002) Serrated adenoma developing into advanced colon cancer in 2 years. J Gastroenterol 37:467-470
15. Azimuddin K, Stasik JJ, Khubchandani IT, Rosen L, Riether RD, Scarlatto M (2000) Hyperplastic polyps: "more than meets the eye"? Dis Colon Rectum 43:1309-1313
16. Goldstein NS, Bhanot P, Odish E, Hunter S (2003) Hyperplastic-like colon polyps that preceded microsatellite unstable adenocarcinomas. Am J Clin Pathol 119:778-796
17. Jass JR, Iino H, Ruszkiewicz A, Painter D, Solomon MJ, Koorey DJ, Furlong KL, Walsh MD, Palazzo J, Edmonston TB, Fishel R, Young J, Leggett BA (2000) Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 47:43-49
18. Kang M, Mitomi H, Sada M, Tokumitsu Y, Takahashi Y, Igarashi M, Katsumata T, Okayasu I (1997) Ki-67, p53, and Bcl-2 expression of serrated adenomas of the colon. Am J Surg Pathol 21:417-443
19. Komori K, Ajioka Y, Watanabe H, Oda K, Nimura Y (2003) Proliferation kinetics and apoptosis of serrated adenoma of the colorectum. Pathol Int 53:277-283
20. Chan TL, Zhao W, Leung SY, Yuen ST, Cancer Genomic Project (2003) BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63:4878-4881
21. Jass JR (2005) Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2:398-405
22. Otori K, Oda Y, Sugiyama K, Hasebe T, Mukai K, Fujii T, Tajiri H, Yoshida S, Fukushima S, Esumi H (1997) High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut 40:660-663
23. Ajioka Y, Watanabe H, Jass JR, Yokota Y, Kobayashi M, Nishikura M (1998) Infrequent K-ras codon 12 mutation in serrated adenomas of human colorectum. Gut 42:680-684
24. Higuchi T, Jass JR (2004) My approach to serrated polyps of the colorectum. J Clin Pathol 57:682-686
25. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phophorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241
26. Cardone MH, Roy S, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC (1998) Regulation of cell death protease caspase-9 by phophorylation. Science 282:1318-1321
27. Fenton RG, Hixon JA, Wright PW, Brooks AD, Sayers TJ (1998) Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras. Cancer Res 58:3391-3400
28. Jass JR (2002) Serrated adenoma of the colorectum. Current Diag Pathol 8:42-49
29. Ramaswamy S, Golub TR (2002) DNA microarrays in clinical oncology. J Clin Oncol 20:1932-1941
30. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Lu JL, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511
31. Pusztai L, Hess KR (2004) Clinical trial design for microarray predictive marker discovery and assessment. Annals Oncol 15:1731-1737
32. de Bolle X, Bayliss CD (2003) Gene expression technology. Methods Mol Med 71:135-146
33. Kwon HC, Kim SH, Roh MS, Kim JS, Lee HS, Choi HJ, Jeong JS, Kim HJ, Hwang TH (2004) Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis Colon Rectum 47:141-152
34. Notterman DA, Alon U, Sierk AJ, Levine AJ (2001) Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61:3124-3130
35. Barrier A, Boelle PY, Lemoine A, Tse C, Brult D, Chiappini F, Lacaine F, Houry S, Huguier M, Flahault A, Du t S (2005) Gene expression profiling of nonneoplastic mucosa may predict clinical outcome of colon cancer patients. Dis Colon Rectum 48:2238-2248
36. Bertucci F, Salas S, Eysterier S, Nasser V, Finetti P, Ginestier C, Churafe-Jauffret E, Lorid B, Bachelart V, Monfort J, Victorero G, Nguyen C, Viens P, Monges G, Birnbaum D, Houlgatte R (2004) Gene expression profiling of colon cancer and correlation with histoclinical parameters. Oncogene 23:1377-1391
37. Sakai Y, Meno C, Fujii H, Nishino J, Shiratori H, Saijoh Y, Rossant J, Hamada H (2001) The retinoic acid-inactivating enzyme CYP26 is essential for establishing an uneven distribution of retinoic acid along the anterior-posterior axis within the mouse embryo. Genes & Dev 15:213-225
38. Soprano DR, Scanlon E, Shukri M, Zhang ZP, Soprano KJ (2000) Murine RARβ4 displays transactivation activity, lower affinity for retinoic acid, and no anti-AP1 activity. J Cell Biochem 77:604-614
39. de Marco MDC, Kremer L, Albar JP, Martinez-Menarguez JA, Bellesta J, Garcia-Lopez MA, Marazuela M, Puertollano R, Alonso MA (2001) BENE, a novel raft-associated protein of the MAL proteolipid family, interacts with caveolin-1 in human endothelial-like ECV304 cells. J Biol Chem 276:23009-23017
40. Carver LA, Schnitzer JE, Anderson RGW, Mohla S (2003) Role of caveolae and lipid rafts in cancer. Cancer Res 63:6571-6574
41. Patrolla JMR, Swamy MV, Raju J, Rao CV (2004) Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines. Oncol Rep 11:957-963
42. Kim HA, Kim KH, Lee RA (2006) Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues. Exp Mol Pathol 80:165-170
43. Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T, Okushiba S, Kondo S, Katoh H (2002) Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94:929-933
44. Idriss HT, Naismith JH (2000) TNFα and the TNF receptor superfamily: Structure-function relationship. Microsc Res Tech 50:184-195
45. Nagata S (1993) Apoptosis by death factor. Cell 75:1169-1178
46. Shimoyama M, Kanda T, Liu L, Koyama Y, Suda T, Sakai Y, Hatakeyama K (2001) Expression of Fas ligand is an early event in colorectal carcinogenesis. J Surg Oncol 76:63-68
47. Kitahara O, Furukawa Y, Tanaka T, Kihara C, Ono K, Yanagawa R (2001) Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 61:3544-3549
48. Takemasa I, Higuchi H, Yamamoto H, Sekimoto M, Tomiya N, Nakamori S, Matoba R, Monden M, Matsubara K (2001) Construction of preferential cDNA microarray specialized for human colorectal carcinoma: Molecular sketch of colorectal cancer. Biochem Biophys Res Commun 285:1244-1249
49. Otsuka M, Kato M, Yoshikawa T, Chen H, Brown EJ, Masuho Y, Omata M, Seki N (2001) Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis. Biochem Biophys Res Commun 289:876-881
50. Birkenkamp-Demtroder K, Christensen LL, Olsen SII, Frederiksen CM, Laiho P, Aaltonen LA, Larberg S, Sorensen FB, Hagemann R, Orntoft T (2002) Gene expression in colorectal cancer. Cancer Res 62:4352-4363